BerganKDV Wealth Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-14
Closed -$381 – 1081
2022
Q4
$381 Hold
14
– – ﹤0.01% 976
2022
Q3
$1K Hold
14
– – ﹤0.01% 888
2022
Q2
$1K Buy
+14
New +$694 ﹤0.01% 903
2021
Q4
– Sell
-100
Closed -$13K – 1084
2021
Q3
$13K Hold
100
– – ﹤0.01% 594
2021
Q2
$12K Buy
+100
New +$13.5K ﹤0.01% 579

Other funds holding GH

BerganKDV Wealth Management's GH Position: Q1 2023 in Review

BerganKDV Wealth Management sold out of Guardant Health (GH) in Q1 2023, closing a stake of 14 shares — an estimated $381 sold.

BerganKDV Wealth Management first reported a position in GH in Q2 2021 and held it in 5 quarters. The position peaked at $13K in Q3 2021. 279 funds tracked by Wall St. Rank hold GH as of Q1 2023.

  • BerganKDV Wealth Management reported no remaining Guardant Health position as of Q1 2023 after selling out during the quarter.
  • BerganKDV Wealth Management sold 14 Guardant Health shares in Q1 2023, an estimated $381.
  • BerganKDV Wealth Management first reported a position in Guardant Health in Q2 2021 and held it in 5 quarters.
  • BerganKDV Wealth Management's Guardant Health position peaked at $13K in Q3 2021.
  • 279 funds tracked by Wall St. Rank held Guardant Health as of Q1 2023.

Based on BerganKDV Wealth Management's 13F filing for Q1 2023, filed 27 Apr 2023.